These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9213085)

  • 21. [Psychotherapy and drugs. Conquering panic].
    Boerner RJ
    MMW Fortschr Med; 2002 May; Suppl 2():65-9. PubMed ID: 12070855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exacerbation of respiratory symptoms in patients with panic disorder.
    Bouwer CD; Stein DJ; Hawkridge SM
    Am J Psychiatry; 1997 May; 154(5):712-3. PubMed ID: 9137136
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of citalopram treatment on platelet serotonin function in panic disorders.
    Neuger J; Wistedt B; Sinner B; Aberg-Wistedt A; Stain-Malmgren R
    Int Clin Psychopharmacol; 2000 Mar; 15(2):83-91. PubMed ID: 10759339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.
    Bell C; Forshall S; Adrover M; Nash J; Hood S; Argyropoulos S; Rich A; Nutt DJ
    J Psychopharmacol; 2002 Mar; 16(1):5-14. PubMed ID: 11949771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of quality of life in panic disorder with escitalopram, citalopram, or placebo.
    Bandelow B; Stein DJ; Dolberg OT; Andersen HF; Baldwin DS
    Pharmacopsychiatry; 2007 Jul; 40(4):152-6. PubMed ID: 17694478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia.
    Bakker A; van Balkom AJ; van Dyck R
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S25-30. PubMed ID: 11110016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
    Mochcovitch MD; Nardi AE
    Expert Rev Neurother; 2010 Aug; 10(8):1285-93. PubMed ID: 20662754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of escitalopram on metabolic parameters in patients with major depressive disorder, generalised anxiety disorder, and panic disorder: a prospective 6-month follow-up study.
    Peh AL; Nieng CH; Ling YH; Kheng TW; Neng TS; Koon OG
    Asian J Psychiatr; 2013 Jun; 6(3):256-7. PubMed ID: 23642988
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis.
    Boyer W
    Int Clin Psychopharmacol; 1995 Mar; 10(1):45-9. PubMed ID: 7622804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The side effect burden associated with drug treatment of panic disorder.
    Baldwin DS; Birtwistle J
    J Clin Psychiatry; 1998; 59 Suppl 8():39-44; discussion 45-6. PubMed ID: 9707161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
    Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L
    Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interpersonal psychotherapy for depression with panic spectrum symptoms: a pilot study.
    Cyranowski JM; Frank E; Shear MK; Swartz H; Fagiolini A; Scott J; Kupfer DJ
    Depress Anxiety; 2005; 21(3):140-2. PubMed ID: 15965998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of epilepsy complicated by panic disorder and a non-specific reaction to a SSRI].
    Wanders AJ; de Leeuw AS; van Megen HJ
    Tijdschr Psychiatr; 2010; 52(5):349-52. PubMed ID: 20458682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
    Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
    J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of electric shock-like sensations on escitalopram discontinuation.
    Prakash O; Dhar V
    J Clin Psychopharmacol; 2008 Jun; 28(3):359-60. PubMed ID: 18480703
    [No Abstract]   [Full Text] [Related]  

  • 37. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
    Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
    Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Cytochrome P450 2C19 Genetic Polymorphisms on Responses to Escitalopram and Levels of Brain-Derived Neurotrophic Factor in Patients With Panic Disorder.
    He Q; Mei Y; Liu Y; Yuan Z; Zhang J; Yan H; Shen L; Zhang Y
    J Clin Psychopharmacol; 2019; 39(2):117-123. PubMed ID: 30742590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication treatments for panic disorder and social phobia.
    Stein MB
    Depress Anxiety; 1998; 7(3):134-8. PubMed ID: 9656095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citalopram in the treatment of depression and other potential uses in psychiatry.
    Tan JY; Levin GM
    Pharmacotherapy; 1999 Jun; 19(6):675-89. PubMed ID: 10391413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.